Rosuvastatin-Induced Oral Ulcer: A Case Report and Review of Literature
- PMID: 35392489
- PMCID: PMC8983251
- DOI: 10.1155/2022/7960513
Rosuvastatin-Induced Oral Ulcer: A Case Report and Review of Literature
Abstract
Background: The benefits of prescribing statins are well published in the treatment of hypercholesterolemia. With such widespread usage of statins, physicians may be ignoring or misdiagnosing the association of oral side effects with these medications. Case Summary. A 54-year-old man presented with a painful ulceration on the dorsum of his tongue that had been recurring for 10 months. Originally, he experienced a burning sensation on his tongue, and as the lesion advanced, the pain became more intense specially when consuming spicy or acidic foods. He is on rosuvastatin for the treatment of hypercholesterolemia for over five years. Several months prior to the lesion forming, his physician increased his daily dosage of rosuvastatin from 10 mg to 20 mg. Four weeks later at a follow-up appointment, all workup did not show any significant findings, the examination revealed a new ulcer on the dorsum of the tongue, and he reported no improvement after antifungal lozenges, nor when administered a short one-week treatment with oral steroids. After eight weeks of statin discontinued, the patient showed improvement with no episodes of ulceration.
Conclusion: Physicians do note that statins affect multiple immunological pathways, which could explain some adverse cutaneous reactions. More research is needed in discovering the link of statins and oral disorders.
Copyright © 2022 Metab Algeffari and Mansour Alsharidah.
Conflict of interest statement
The authors have stated explicitly that there are no conflicts of interests in connection with this article.
Figures
References
-
- Grundy S. M., Stone N. J., Bailey A. L., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation . 2019;139(25) doi: 10.1161/CIR.0000000000000625. - DOI - PMC - PubMed
-
- Aitken M., Kleinrock M., Lyle J., Caskey L. Medicine use and shifting costs of healthcare: a review of the use of medicines in the United States in 2013. IMS Institute for Healthcare Informatics IMS Health . 2014
-
- Alberts A. W., Chen J., Kuron G., et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proceedings of the National Academy of Sciences of the United States of America . 1980;77(7):3957–3961. doi: 10.1073/pnas.77.7.3957. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
